New Sanofi-Aventis Breast Cancer Drug Shows Little Benefit
Clinical trials of a new Sanofi-Aventis drug, iniparib, showed dismal results at treating and improving survival rates of patients with breast cancer.
Clinical trials of a new Sanofi-Aventis drug, iniparib, showed dismal results at treating and improving survival rates of patients with breast cancer.
The chances of a woman with an eating disorder having an abortion far exceeds that of a woman who does not have an eating disorder.
What researchers found was a medication to potentially decrease risks of contracting HIV.
A new study shows that people affected with severe mental disorders like bipolar disorder or schizophrenia, notice significantly higher suicide rates than individuals without these disorders.
Researchers have developed a program that can not only improve driving skills of these potentially dangerous teens, but also can help improve relationships with friends and family.
New research shows that friend and relationship choices may be largely influenced by genetic makeup instead of just similar interests and activities.
A new study involving individuals with irritable bowel syndrome may have discovered a potential relief of certain IBS symptoms.
A new study explains individuals may be more likely to survive cardiac arrest if it occurs in public than if they receive shock therapy at home.
When analyzing the diseased cells under a microscope, there is a protein that binds two separate diseases together.
While some believe Taco Bell tacos are not all they’re cracked up to be, the company defends allegations that their products are in fact all beef.